A Phase I Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Single and Multiple Doses of AL002 in Healthy Participants and in Participants with Mild to Moderate Alzheimer's Disease.

Project: Research

StatusActive
Effective start/end date30/05/1931/12/19

Keywords

  • Neurological disorders
  • Alzheimer's disease
  • Clinical trial